Clinical Trials Insight: 700020217
Phase of Trial: Phase I/II
Latest Information Update: 19 Jun 2008
At a glance
- Drugs Antineoplastics; MVA BN HER2
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bavarian Nordic
- 19 Jun 2008 Interim results reported in a Bavarian Nordic media release (9090334).
- 29 Apr 2008 Enrolment is continuing as planned, according to a Bavarian Nordic media release.
- 29 Apr 2008 Results data is expected in quarter 2 2008, according to a Bavarian Nordic media release.